The Korean Ministry of Food and Drug Safety recently approved a Phase IIb clinical trial for Dangook University Hospital’s Dermatology Department to study the efficacy of botulinum toxin Nabota for the treatment of hair loss on 48 male study participants. Sponsored...
Drug marker Sanofi is under fire with at least 13,200 lawsuits with more expected due to plaintiff’s permanent hair loss. Temporary hair loss was a known side effect but permanent hair loss caught patients by surprise What is Taxotere? It is a chemotherapy medication...
As reported in Korea Biomedical Review, Lilly Korea is conducting a clinical trial on rheumatoid arthritis drug Olumiant (baricitinib) to test whether it will be effective for alopecia areata—spot baldness. Recently, the Korean Ministry of Food and Drug Safety...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
